Weekly Digest – May 2024 Weekly Digest – May 2024 13 May 2024: Mabwell updates on clinical progress of 9MW2821 for Triple-Negative Breast Cancer Mabwell announced progress on the clinical study of 9MW2821, a Nectin-4-targeting ADC, for triple-negative breast cancer […]
Weekly Digest – May 2024 Weekly Digest – May 2024 14 May 2024: Minghui Pharmaceutical to present phase I/II study of MHB088C (B7-H3 ADC) for recurrent or metastatic solid tumors at 2024 ASCO meeting Minghui Pharmaceutical will present Phase III […]
Weekly Digest – May 2024 Weekly Digest – May 2024 15 May 2024: Merck to showcase innovative oncology treatments at 2024 ASCO annual meeting Merck will present new data on four approved oncology medicines and four pipeline candidates across more […]
